Form4insider filings, from the source

Insider holders · CIK 0001302573

OncoMed Pharmaceuticals Inc · OMED

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
Denise Pollard-KnightDirector—1,943,5091,943,509Jan 2, 2015 · 3:33 pm ESTForm 4
Terry P GouldDirector—592,953592,953Dec 2, 2015 · 5:09 pm ESTForm 4
Jack W LasersohnDirector185,709380,299566,008May 26, 2017 · 5:51 pm EDTForm 4
Paul J HastingsChairman & CEO76,188324,840401,028Oct 12, 2017 · 6:35 pm EDTForm 4
John A. LewickiPresident & CEO44,173111,181155,354Feb 13, 2019 · 7:51 pm ESTForm 5
Jonathan D RootDirector121,0200121,020May 26, 2017 · 11:57 am EDTForm 4
Perry A KarsenDirector80,500—80,500Feb 28, 2018 · 4:45 pm ESTForm 4
Timothy HoeySVP, Cancer Biology & Co-CSO77,225—77,225Apr 25, 2017 · 6:13 pm EDTForm 4
Yvonne LiSee Remarks77,137—77,137Feb 13, 2019 · 7:52 pm ESTForm 5
Sunil PatelSee Remarks68,336—68,336Oct 12, 2017 · 6:36 pm EDTForm 4
Austin GurneySee Remarks66,807—66,807Dec 26, 2018 · 4:35 pm ESTForm 4
Alicia J. HagerSVP & General Counsel51,754—51,754Oct 11, 2018 · 6:56 pm EDTForm 4
Robert StaggSVP, Clinical R&D40,670—40,670Oct 11, 2018 · 7:00 pm EDTForm 4
Jakob DupontSVP & Chief Medical Officer34,440—34,440Oct 11, 2016 · 9:42 pm EDTForm 4
Laurence LaskyDirector10,332—10,332Dec 2, 2015 · 6:53 pm ESTForm 4

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.